Barriers and enablers to diabetic eye screening: a cross sectional survey of young adults with type 1 and type 2 diabetes in the UK
View ORCID ProfileLouise Prothero, View ORCID ProfileMartin Cartwright, View ORCID ProfileFabiana Lorencatto, View ORCID ProfileJennifer M Burr, View ORCID ProfileJohn Anderson, Philip Gardner, View ORCID ProfileJustin Presseau, View ORCID ProfileNoah Ivers, View ORCID ProfileJeremy M Grimshaw, View ORCID ProfileJohn G Lawrenson, the EROS Study Investigators
doi: https://doi.org/10.1101/2022.05.24.22275352
Louise Prothero
1School of Health Sciences, City, University of London, UK
Martin Cartwright
1School of Health Sciences, City, University of London, UK
Fabiana Lorencatto
2Centre for Behaviour Change, University College London, UK
Jennifer M Burr
3School of Medicine, University of St Andrews, UK
John Anderson
4Homerton University Hospital NHS Foundation Trust, London, UK
Philip Gardner
5Department of Health and Social Care, London, UK
Justin Presseau
6Ottawa Hospital Research Institute, Ottawa Canada
7School of Epidemiology and Public Health, University of Ottawa, Ottawa, Canada
Noah Ivers
8Women’s College Research Institute, Toronto, Canada
Jeremy M Grimshaw
5Department of Health and Social Care, London, UK
9Department of Medicine, University of Ottawa, Ottawa, Canada
John G Lawrenson
1School of Health Sciences, City, University of London, UK
Data Availability
All data produced in the present study are available upon reasonable request to the authors
Posted May 24, 2022.
Barriers and enablers to diabetic eye screening: a cross sectional survey of young adults with type 1 and type 2 diabetes in the UK
Louise Prothero, Martin Cartwright, Fabiana Lorencatto, Jennifer M Burr, John Anderson, Philip Gardner, Justin Presseau, Noah Ivers, Jeremy M Grimshaw, John G Lawrenson, the EROS Study Investigators
medRxiv 2022.05.24.22275352; doi: https://doi.org/10.1101/2022.05.24.22275352
Barriers and enablers to diabetic eye screening: a cross sectional survey of young adults with type 1 and type 2 diabetes in the UK
Louise Prothero, Martin Cartwright, Fabiana Lorencatto, Jennifer M Burr, John Anderson, Philip Gardner, Justin Presseau, Noah Ivers, Jeremy M Grimshaw, John G Lawrenson, the EROS Study Investigators
medRxiv 2022.05.24.22275352; doi: https://doi.org/10.1101/2022.05.24.22275352
Subject Area
Subject Areas
- Addiction Medicine (399)
- Allergy and Immunology (708)
- Anesthesia (201)
- Cardiovascular Medicine (2942)
- Dermatology (249)
- Emergency Medicine (439)
- Epidemiology (12743)
- Forensic Medicine (12)
- Gastroenterology (828)
- Genetic and Genomic Medicine (4583)
- Geriatric Medicine (417)
- Health Economics (729)
- Health Informatics (2916)
- Health Policy (1069)
- Hematology (389)
- HIV/AIDS (924)
- Medical Education (425)
- Medical Ethics (115)
- Nephrology (469)
- Neurology (4351)
- Nursing (236)
- Nutrition (639)
- Oncology (2268)
- Ophthalmology (646)
- Orthopedics (258)
- Otolaryngology (325)
- Pain Medicine (279)
- Palliative Medicine (83)
- Pathology (501)
- Pediatrics (1196)
- Primary Care Research (496)
- Public and Global Health (6937)
- Radiology and Imaging (1527)
- Respiratory Medicine (915)
- Rheumatology (437)
- Sports Medicine (385)
- Surgery (488)
- Toxicology (60)
- Transplantation (212)
- Urology (180)